Version 1
: Received: 20 December 2016 / Approved: 20 December 2016 / Online: 20 December 2016 (10:34:56 CET)
How to cite:
Caballero, M.V.; Candiracci, M. Zebrafish as Toxicological Model for Screening and Recapitulate Human Diseases. Preprints2016, 2016120103 (doi: 10.20944/preprints201612.0103.v1).
Caballero, M.V.; Candiracci, M. Zebrafish as Toxicological Model for Screening and Recapitulate Human Diseases. Preprints 2016, 2016120103 (doi: 10.20944/preprints201612.0103.v1).
Cite as:
Caballero, M.V.; Candiracci, M. Zebrafish as Toxicological Model for Screening and Recapitulate Human Diseases. Preprints2016, 2016120103 (doi: 10.20944/preprints201612.0103.v1).
Caballero, M.V.; Candiracci, M. Zebrafish as Toxicological Model for Screening and Recapitulate Human Diseases. Preprints 2016, 2016120103 (doi: 10.20944/preprints201612.0103.v1).
Abstract
Embryonic and larval Danio rerio is increasingly used as a toxicological model to conduct rapid in vivo tests and developmental toxicity assays; the zebrafish features as high genetic homology to mammals; robust phenotypes; and its value in high-throughput genetic and chemical screening have made it a powerful tool to evaluate in vivo toxicity. New methodologies of genome editing as CRISPR/Cas9; ZFN or Talen make it a suitable model to perform studies to pair human genetic diseases as well. This review surveys recent studies; employing zebrafish as experimental model; comparing it with other in vivo and in vitro models; presenting zebrafish as a potent vertebrate tool to evaluate drug toxicity to facilitate more extensive; easy and comprehensive knowledge of new generation drugs.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.